G. Shi

Zhao-You Tang, Yuan Ji, Wei Zhang, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway

Huichuan Sun, A. Ke, N. Ren, 2022, Journal of Experimental & Clinical Cancer Research.

BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma

Jia Fan, Chi Zhang, A. Ke, 2015, International journal of immunopathology and pharmacology.

UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2

Chi Zhang, A. Ke, Peng-fei Zhang, 2016, Oncotarget.

Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients

Quan-lin Li, Jia Fan, Jian Zhou, 2010, Cancer.

The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangiocarcinoma as Second-Line and Successive Treatment: A Real-World Study

Peixin Huang, Yingting Zhou, G. Shi, 2022, Canadian journal of gastroenterology & hepatology.

Intratumoral IL-17+ Cells and Neutrophils show Strong Prognostic Significance in Intrahepatic Cholangiocarcinoma

Q. Gao, Jian Zhou, Yinghong Shi, 2012, Annals of Surgical Oncology.

USP 7 accelerates p 14 ARF degradation by deubiquitinating TRIP 12 and promotes HCC progression

S. Qiu, Q. Gao, Jia Fan, 2014 .

Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma

Jia Fan, Jian Zhou, Wei-ren Liu, 2012, Cancer.

Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma

D. Gao, Xuan Yang, Chi Zhang, 2017, Cell Death & Disease.

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study

Xia Li, Haifeng Zhao, Jia Fan, 2022, Cancer medicine.

Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma

A. Ke, Jian Zhou, Dongmei Gao, 2022, Gut microbes.

Proteogenomic characterization of cholangiocarcinoma

Yingyong Hou, Jia Fan, Yuan Ji, 2022, Hepatology.

Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC

S. Qiu, Ya Cao, Jia Fan, 2016, Oncotarget.

Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma

Jia Fan, Jian Zhou, Yinghong Shi, 2021, Journal of Hematology & Oncology.

Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors

Jia Fan, Jian Zhou, Yinghong Shi, 2019, Theranostics.

Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection

Zhi-quan Wu, Zhao-You Tang, S. Qiu, 2008, Clinical Cancer Research.

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma

Wei Zhang, Chuan He, Hongyang Wang, 2019, Gut.

5-Hydroxymethylcytosines from Circulating Cell-free DNA as Diagnostic and Prognostic Markers for Hepatocellular Carcinoma

Wei Zhang, Chuan He, Hongyang Wang, 2018, bioRxiv.

Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro

Chi Zhang, A. Ke, Peng-fei Zhang, 2017, Journal of Clinical Pathology.

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

J. Yun, Yaming Li, C. Liang, 2020, Liver Cancer.

Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis

S. Qiu, Jia Fan, Jian Zhou, 2011, Autophagy.

Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation

Jia Fan, Jian Zhou, Yinghong Shi, 2011, Clinical Cancer Research.

Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.

S. Qiu, Jia Fan, Jian Zhou, 2008, Cancer research.

Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer

Fei Lan, Yiming Li, Jia Fan, 2018, Nature.

HNRNPAB‐regulated lncRNA‐ELF209 inhibits the malignancy of hepatocellular carcinoma

G. Zhu, Jia Fan, Jian Zhou, 2019, International journal of cancer.

Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors

Jian Sun, Yingyong Hou, Zheng Wang, 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.

Xianghuo He, S. Qiu, Q. Gao, 2014, Gastroenterology.

MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.

Q. Gao, Jia Fan, Jian Zhou, 2018, Cancer letters.

Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma

S. Qiu, Q. Gao, Jia Fan, 2013, Clinical Cancer Research.

Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing

Q. Gao, Jia Fan, Jian Zhou, 2014, Hepatology.

High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma

S. Qiu, Jia Fan, Jian Zhou, 2010, Gut.

Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection

Jue Fan, F. Lan, Jian Zhou, 2020, bioRxiv.

NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells

Xiao-dong Zhu, Bo Hu, Jia Fan, 2018, Journal of Hematology & Oncology.

Low Level of Low-Density Lipoprotein Receptor-Related Protein 1 Predicts an Unfavorable Prognosis of Hepatocellular Carcinoma after Curative Resection

W. Jia, Z. Wang, Zhao-You Tang, 2012, PloS one.

Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures

Ke-can Lin, Jia Fan, Jian Zhou, 2022, Hepatology International.

Circular RNA circTRIM33–12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression

D. Gao, Jia Fan, Xuan Yang, 2019, Molecular Cancer.

CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery

S. Qiu, Jia Fan, Jian Zhou, 2009, Clinical Cancer Research.

Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult.

Z. Gong, Jia Fan, Ruoyu He, 2018, Cancer research.

Lymphoid‐specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression

Jia Fan, Jian Zhou, Xuan Yang, 2019, Cancer science.

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma

Q. Gao, Jia Fan, Xuan Yang, 2019, Journal of Experimental & Clinical Cancer Research.

TET2 promotes anti‐tumor immunity by governing G‐MDSCs and CD8+ T‐cell numbers

Y. Shi, Li Tan, Jia-bin Cai, 2020, EMBO reports.

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma

Jia Fan, Jian Zhou, Yinghong Shi, 2021, Frontiers in Immunology.

Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications

Jia Fan, Jian Zhou, Chi Zhang, 2015, Tumor Biology.

CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity

Wei Zhou, Jia Fan, A. Ke, 2021, Molecular cancer.

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation

Z. Wang, Zhao-You Tang, S. Qiu, 2011, PloS one.

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis

Jia Fan, Jian Zhou, Xuan Yang, 2023, Cell Death & Disease.

Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2020, Annals of translational medicine.

Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinoma

Q. Gao, Jia Fan, Jian Zhou, 2014, Oncology letters.

Mitogen‐activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial‐mesenchymal transition

D. Gao, S. Qiu, Q. Gao, 2015, Hepatology.

Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial

Jian Sun, Q. Ye, S. Qiu, 2020, Annals of translational medicine.

Predicting overall survival of patients with hepatocellular carcinoma using a three‐category method based on DNA methylation and machine learning

Jia Fan, Jian Zhou, Xuan Yang, 2019, Journal of cellular and molecular medicine.

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

S. Qiu, Jian Zhou, Jian Sun, 2023, Signal Transduction and Targeted Therapy.

KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma

Q. Gao, Jia Fan, Wei-ren Liu, 2022, Cancer cell international.

Ubiquitin‐specific protease 7 accelerates p14ARF degradation by deubiquitinating thyroid hormone receptor‐interacting protein 12 and promotes hepatocellular carcinoma progression

S. Qiu, Q. Gao, Jia Fan, 2015, Hepatology.

Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

Jia Fan, Jian Zhou, Xuan Yang, 2020, Molecular Cancer.

Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/Integrin β1 Complex in the Progression of Hepatocellular Carcinoma

Jia Fan, Jian Zhou, Yinghong Shi, 2011, PloS one.

CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.

Xianghuo He, S. Qiu, Q. Gao, 2012, Cancer research.

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma

Q. Gao, Jia Fan, Jian Zhou, 2019, Cancer Cell International.

Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinoma.

Q. Gao, Jia Fan, Jian Zhou, 2016, International journal of oncology.

Imaging , Diagnosis , Prognosis Margin-In fi ltratingCD 20 þ BCellsDisplay anAtypicalMemory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma

S. Qiu, Q. Gao, Jia Fan, 2013 .

Liver‐intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus‐positive hepatocellular carcinoma

S. Qiu, Jia Fan, Jian Zhou, 2009, Cancer.

Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection.

Zhao-You Tang, S. Qiu, Jia Fan, 2008, The oncologist.

CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma

S. Qiu, Jia Fan, Jian Zhou, 2010, Hepatology.

Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

Jia Fan, Xuan Yang, A. Ke, 2020, Molecular Cancer.

Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma

A. Ke, Peng-fei Zhang, Xiao-jun Guo, 2020, Molecular Cancer.

Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2018, American journal of translational research.

Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor–induced epithelial‐mesenchymal transition

D. Gao, Q. Gao, Ya Cao, 2015, Hepatology.

Dexamethasone for postoperative hyperbilirubinemia in patients after liver resection: An open‐label, randomized controlled trial

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2019, Surgery.

αB‐crystallin complexes with 14‐3‐3ζ to induce epithelial‐mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma

S. Qiu, Yong-sheng Xiao, Jia Fan, 2013, Hepatology.

The long noncoding RNA NORAD enhances the TGF‐β pathway to promote hepatocellular carcinoma progression by targeting miR‐202‐5p

Jia Fan, Xuan Yang, A. Ke, 2018, Journal of cellular physiology.

Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B‐related hepatocellular carcinoma

Jia Fan, Jian Zhou, Xuan Yang, 2021, Clinical and translational medicine.

Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition

Zhao-You Tang, Jia Fan, Jian Zhou, 2011, Clinical Cancer Research.

A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study.

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2020, Surgery.

The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion

Yinghong Shi, A. Ke, Xiao-jun Guo, 2022, Hepatology International.

Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials

Jiang Zhu, Jia Fan, Yong Liao, 2008, Journal of Cancer Research and Clinical Oncology.

Lenvatinib plus toripalimab as first-line treatment for advanced intrahepatic cholangiocarcinoma: A single-arm, phase 2 trial.

Q. Ye, S. Qiu, Jia Fan, 2021 .

56P Anti-PD1 antibody toripalimab, lenvatinib and gemox chemotherapy as first-line treatment of advanced and unresectable intrahepatic cholangiocarcinoma: A phase II clinical trial

Yingyong Hou, S. Qiu, Yang Xu, 2020 .

Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma

Jia Fan, Jian Zhou, Chi Zhang, 2013, PloS one.

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

Chi Zhang, A. Ke, Chuanyuan Wei, 2023, Cancer letters.

Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment.

Jian Zhou, Wei-ren Liu, Yinghong Shi, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma

Q. Gao, Jia Fan, Jian Zhou, 2019, Cancer Cell International.

Deep learning to develop transcriptomic model for survival prediction in TCGA patients with hepatocellular carcinoma.

Chen Hu, F. Kong, A. Chan, 2020 .

Gemox chemotherapy in combination with anti-PD1 antibody toripalimab and lenvatinib as first-line treatment for advanced intrahepatic cholangiocarcinoma: A phase 2 clinical trial.

S. Qiu, Q. Gao, Jia Fan, 2021 .

Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis

S. Qiu, Jia Fan, Jian Zhou, 2017, Journal of Cancer.

Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1

Bo Hu, Wei-feng Liu, Jia Fan, 2023, Hepatology International.

Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma

D. Gao, Xuan Yang, Chi Zhang, 2017, Cell Death & Disease.

Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis.

S. Qiu, Jia Fan, Jian Zhou, 2015, American journal of cancer research.

Future liver volume combined with platelet count predicts liver failure after major hepatectomy.

Xiao-dong Zhu, G. Shi, Cheng Huang, 2022, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

Liver Stiffness Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in Patients with Hepatocellular Carcinoma

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2017, Journal of Gastrointestinal Surgery.

Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.

Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2015, PloS one.

Effect of postoperative apatinib treatment after resection of hepatocellular carcinoma with portal vein invasion: A phase II study.

Jian Sun, Q. Ye, S. Qiu, 2020 .

Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients

B. Peng, Jia Fan, Jian Zhou, 2014, PloS one.

Human Cancer Biology Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial – Mesenchymal Transition

Z. Wang, Zhao-You Tang, Jia Fan, 2011 .

Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis

Q. Ye, S. Qiu, Jia Fan, 2022, Surgical Endoscopy.

Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma

Q. Gao, Jia Fan, Jian Zhou, 2017, Infectious Agents and Cancer.

Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2017, BMC Cancer.

944P Adjuvant camrelizumab combined with apatinib treatment after resection of hepatocellular carcinoma in CNLC II and III stage: A single-center prospective phase II trial

Q. Ye, Q. Gao, G. Shi, 2021, Annals of Oncology.

Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma

Jia Fan, Xiaoying Wang, A. Ke, 2022, Hepatology.

eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation.

F. Lan, Jia Fan, Jian Zhou, 2019, American journal of cancer research.

UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2.

Chi Zhang, A. Ke, Peng-fei Zhang, 2016, Oncotarget.

Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis.

D. Gao, Q. Gao, Ya Cao, 2016, Hepatology.

Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.

S. Qiu, Jia Fan, Jian Zhou, 2008, Cancer research.

Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4.

Xiao-dong Zhu, Bo Hu, Jia Fan, 2018, American journal of cancer research.

Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma.

Yinghong Shi, A. Ke, H. Zeng, 2023, International immunopharmacology.

Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing

Q. Gao, Jia Fan, Jian Zhou, 2014, Hepatology.

Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B

Xiao-dong Zhu, Jia Fan, Jian Zhou, 2017, BMC Cancer.

Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients

Jia Fan, Jian Zhou, Z. Dai, 2010, Cancer.

αB‐crystallin complexes with 14‐3‐3ζ to induce epithelial‐mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma

S. Qiu, Yong-sheng Xiao, Jia Fan, 2013, Hepatology.

Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition

Zhao-You Tang, Jia Fan, Jian Zhou, 2011, Clinical Cancer Research.

Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult.

Z. Gong, Jia Fan, Ruoyu He, 2018, Cancer research.

CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.

Xianghuo He, S. Qiu, Q. Gao, 2012, Cancer research.

Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version)

Jia Fan, Yuan Ji, Zhiyong Huang, 2023, Journal of clinical and translational hepatology.

Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer

C. Lian, Yiming Li, Pengyuan Yang, 2018, Nature.

Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma

S. Qiu, Yinghong Shi, A. Ke, 2024, Nature communications.

Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

A. Ke, Jia Fan, Chao Gao, 2024, Molecular cancer.

PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy

A. Ke, Jian Zhou, Chao Gao, 2023, Advanced science.

Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges

Q. Gao, Jian Zhou, Yinghong Shi, 2022, Journal of Oncology.